Multiple clinical trials and studies involving men and women of all ages have demonstrated that low-level laser therapy (LLLT) could be a safe, pain-free, and effective option for hair growth.

LLLT is an exciting new technology for those wanting to combat thinning hair with evidence on the effectiveness of this treatment growing every day (individual results may vary).

Say Yes! and experience the transformative power of low-level-laser therapy with RedRestore's FDA-Cleared Laser Cap Today!

LLLT was first discovered by accident! It was being used in a trial on mice when scientists discovered it led to increased hair growth. Low-level light therapy is so versatile and promising, that even NASA has used this technology to improve the healing time of their astronauts' wounds.

After the serendipitous discovery, multiple studies followed, eventually determining that laser therapy could be a viable way to increase hair growth and combat thinning & balding hair. Today, this accidental discovery is transforming lives and hairlines around the world!

The RedRestore Laser Cap supports hair regrowth by utilizing specific 650nm wavelengths of laser light energy. This laser energy can help to stimulate the hair follicles to support fuller, thicker hair and can promote the extension of the hair growth cycle.

Discover the results of the following studies and publications and see how LLLT could transform your life today!

1. Published in Lasers in Surgery and Medicine Volume 46, Low-Level Laser (Light) Therapy (LLLT) for Treatment of Hair Loss authored by Harvard Medical School’s Department of Dermatology, Massachusetts General Hospital & Semmelweis University School of Medicine. Researchers concluded that LLLT treatment used immediately post-transplant could promote graft survival and aid in healing. LLLT appears to be a safe, and effective option for promoting hair growth in both men and women.

2. Published in the Journal of Cosmetic & Laser Therapy, The use of low-level light for hair growth: part I authored by Cornell Department of Dermatology. Researchers found that on average patients had a decrease in the number of vellus hairs, an increase in the number of terminal hairs and an increase in shaft diameter. Seven patients were exposed to LLLT twice weekly for 20 minutes over a period of 3-6 months.

3. Published in the International Journal of Dermatology, authored by the Department of Dermatology (Juntendo University School of Medicine, Tokyo, Japan). Seven of 15 (46.7%) patients showed hair regrowth in irradiated areas 1.6 months earlier than compared to non irradiated areas. These findings suggest LLLT devices could be useful as a treatment for mild forms of alopcia areata with its noninvasive properties.

4. The American Society for Dermatologic Surgery conducted a 24-week, randomized, double-blind, sham device-controlled trial to evaluate the efficacy and safety of a LLLT device for the treatment of androgenic alopecia. After 6-months of treatment, LLLT proved to increase hair density compared to other forms of treatment. Additionally, no side effects were reported, and the study concluded that LLLT could prove to be a successful and safe treatment for androgenic alopecia.